The following have provided sponsorship for the Peer Review Congress and associated activities: Pfizer Inc, Elsevier Health Sciences, Aventis Pharma, AstraZeneca, Ediciones Doyma, Merck & Co Inc, Eli Lilly & Co, The Josiah Macy, Jr Foundation, Takeda Pharmaceuticals North America, The Lasker Foundation, Amgen Inc, and Medscape.

Pfizer Inc discovers, develops, manufactures and markets leading prescription medicines, for humans and animals, and many of the world's best known consumer products. Pfizer had global revenues of $29.6 billion in 2000. Pfizer plans to make a research and development investment of about $5 billion in 2001.

Elsevier Health Sciences is the newly formed medical and health sciences division of Elsevier Science, created following the recent acquisition of Harcourt Health Sciences by Reed Elsevier. Elsevier Health Sciences publishes medical and health professional journals, books and electronic products under Elsevier’s imprints, including Elsevier and Excerpta Medica, and Harcourt’s imprints of Saunders, Mosby, Churchill Livingstone and MDConsult. The newly formed division publishes several hundred peer-review primary journals, both proprietary and on behalf of medical and professional societies, in addition to review periodicals, and the Clinics and Year Books. The flagship title The Lancet, in continuous publication since 1823, is published from the division’s London office.

Aventis Pharma, the pharmaceutical company of Aventis, is dedicated to treating and preventing human disease through the discovery, development, manufacture and marketing of innovative pharmaceutical products aimed at satisfying unmet medical needs. Aventis pharma focuses on important therapeutic areas such as cardiology, oncology, infectious diseases, arthritis, allergies and respiratory disorders, diabetes and the central nervous system disorders. Aventis Pharma has its corporate headquarters located in Strasbourg, France. Aventis Pharma encompasses Aventis Pasteur, a world leader in vaccines based in Lyon, France and Aventis Behring, a world leader in therapeutic proteins headquartered in King of Prussia, Pennsylvania, United States.

The Global Medical Publication department leads the medical publication process for all Aventis global strategic products by initiating and managing the production of medical/scientific publications and their submission to peer-reviewed journals and to key scientific congresses.

AstraZeneca (NYSE:AZN) is a major international health care business engaged in the research, development, manufacture, and marketing of ethical (prescription) pharmaceuticals and the supply of health care services. AstraZeneca Group PLC is headquartered in London. AstraZeneca's US Headquarters is located in Wilmington, Delaware. The Company is one of the top 5 pharmaceutical companies in the world with 50,000 employees worldwide, health care sales of $15.8 billion, and leading positions in sales of gastrointestinal, oncology, anesthesia (including pain management), cardiovascular, central nervous system (CNS), and respiratory products. In the United States, AstraZeneca is an $8 billion health care business with more than 10,000 employees.

Ediciones Doyma is the leading Spanish biomedical publishing company with more than 80 journals. Many of them are indexed in the most important bibliographic indexes (Index Medicus, Science Citation Index, Current Contents) such as Medicina Clínica (Med Clin [Barc]) and Revista Española de Cardiología (Rev Esp Cardiol). Doyma also issues the Spanish edition of some prestigious biomedical journals such as Pediatrics, Journal of American College of Cardiology and JAMA. The majority of Doyma’s journals are the official publications of prestigious medical societies. Doyma’s main goal is to be the world’s preferred creator and provider of personalized health information and services in Spanish language, across all distribution platforms and devices. Ediciones Doyma will continue to develop the most complete and precise health publishing projects.

Merck & Co., Inc., headquartered in Whitehouse Station, New Jersey, USA, is a leading research-driven pharmaceutical products and service company. Merck discovers, develops, manufactures, and markets innovative products to improve human health. By means of the Merck Manual, and other respected communication vehicles, Merck educates physicians, patients, and the public about a broad range of medical subjects. Merck pharmaceuticals are marketed worldwide by the Merck Sharp & Dohme division. Merck-Medco Managed Care, Inc., encourages the appropriate use of medicines and provides health management programs. Through these complementary capabilities, Merck works to contain overall health-care costs and improve quality of life.

Lilly is a leading innovation-driven pharmaceutical corporation. We are developing a growing portfolio of best-in-class pharmaceutical products by applying the latest research from our own worldwide laboratories and from collaborations with eminent scientific organizations.

We employ more than 35,000 people worldwide and market our medicines in 159 countries. Lilly has major research and development facilities in 9 countries and conducts clinical trials in more than 30 countries. We provide answers for often complex, difficult problems in two ways: through the discovery and development of breakthrough medicines and through the health information we offer.

At Lilly, people are the source of all our abilities, all our successes. Our future depends on our global community of employees whose varied perspectives, experience and training fuel the creativity and energy to pioneer pharmaceutical innovation.

As our company touches the lives of people worldwide, we recognize that we have a responsibility to be a good corporate citizen in our communities and to help preserve the environment for the generations to come.

The Josiah Macy, Jr Foundation is a privately endowed philanthropy located in the borough of Manhattan, New York City. The Foundation supports programs designed to improve the education of health professionals in the interest of the health of the public, and to enhance the representation of minorities in the health profession.

Established in 1998, Takeda Pharmaceuticals North America, Inc, is a wholly owned subsidiary of Takeda Chemical Industries, Ltd. of Japan. Takeda Chemical Industries was founded over 2 centuries ago and is Japan’s largest pharmaceutical company. With more than 16,000 employees worldwide, Takeda is internationally recognized as a leader in research and development, focusing on treatments for diabetes, cardiovascular and allergic disease, bone and joint disorders, and central nervous system disorders. Takeda Pharmaceuticals North America currently markets Actos (pioglitazone hydrochloride), an oral treatment for type 2 diabetes. Takeda co-promotes Actos in the United States with Eli Lilly and Company. Takeda Pharmaceuticals North America is based in Lincolnshire, Illinois.

The Mary Woodard Lasker Charitable Trust supports programs that educate and increase public awareness about the needs and promises of medical science. The Albert Lasker Medical Research Awards recognize scientists, physicians, and public servants who have made major advances in the understanding, prevention, cure, and prevention of human disease. Since the Awards were established in 1945, 63 Lasker laureates have gone on to win the Nobel Prize.

Amgen is the world's largest independent biotechnology company. We aspire to be the best human therapeutics company. We live the Amgen values and use science and innovation to dramatically improve people's lives. Amgen is a global biotechnology company that discovers, develops, manufactures and markets cost-effective human therapeutics based on advances in cellular and molecular biology.

Amgen is the leading maker of commercialized products, such as Epogen (Epoetin alfa) and Neupogen (G-CSF, Filgrastim). Epogen is a recombinant human erythropoeitin used to treat anemia associated with chronic renal failure for patients on dialysis by stimulating the production of red blood cells. Neupogen selectively stimulates the growth of infection-fighting white blood cells and is used to prevent infection in cancer patients undergoing certain types of chemotherapy and bone marrow transplants, and supports treatment of patients with acute myeloid leukemia.

Amgen, which has approximately 7,000 staff members worldwide, has its headquarters in Thousand Oaks, California.

Medscape (NASDAQ: MDLI) is the leading provider of digital health records and online medical information. The Company delivers patient-centered, clinical healthcare data and up-to-the-minute medical information to health care professionals and consumers anytime and anywhere that information is needed. The core of Medscape's industry-leading product portfolio is the Digital Health Record (DHR). DHR applications and services are an integral part of the practice of medicine and are used everyday by physicians and consumers across the country. More than 17.2 million patients now have digital records hosted on Medscape systems.
Medscape.com is also the leading source of peer-reviewed medical information and continuing medical education on the Web. Approximately 3.3 million members, including 560,000 registered as physicians and more than 1.6 million registered as allied health professionals, use Medscape.com for immediate access to research, recent developments and information to guide their practices and support patient care. In addition, one-third of these members are international physicians and healthcare professionals world-wide. Consumers too have come to rely on CBSHealthWatch by Medscape for health information that comes from the same source their physicians use.

The integration of Medscape's authoritative Web sites with the breadth of its clinical applications and products, strengthen the physician-patient relationship at—and beyond—each encounter, resulting in a positive impact on healthcare costs, efficiencies, safety and outcomes.

Peer Review Congress home